Evexia Lifecare [EVEXIA] vs Britannia Industries [BRITANNIA] Detailed Stock Comparison
Evexia Lifecare
BSE
Loading...
Britannia Industries
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Evexia Lifecare wins in 4 metrics, Britannia Industries wins in 14 metrics, with 0 ties. Britannia Industries appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Evexia Lifecare | Britannia Industries | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 201.00 | 65.79 | Britannia Industries |
| Price-to-Book Ratio | 0.41 | 33.14 | Evexia Lifecare |
| Debt-to-Equity Ratio | 82.72 | 28.45 | Britannia Industries |
| PEG Ratio | N/A | 21.92 | N/A |
| EV/EBITDA | 113.42 | 45.45 | Britannia Industries |
| Profit Margin (TTM) | 1.19% | 12.02% | Britannia Industries |
| Operating Margin (TTM) | 3.91% | 14.60% | Britannia Industries |
| EBITDA Margin (TTM) | 3.91% | 14.60% | Britannia Industries |
| Return on Equity | 0.20% | 49.73% | Britannia Industries |
| Return on Assets (TTM) | 0.10% | 24.65% | Britannia Industries |
| Free Cash Flow (TTM) | $-342.38M | $21.06B | Britannia Industries |
| Dividend Yield | N/A | 2.57% | N/A |
| 1-Year Return | -52.15% | -1.53% | Britannia Industries |
| Price-to-Sales Ratio (TTM) | 3.39 | 7.91 | Evexia Lifecare |
| Enterprise Value | $5.74B | $1,443.68B | Britannia Industries |
| EV/Revenue Ratio | 5.16 | 7.91 | Evexia Lifecare |
| Gross Profit Margin (TTM) | 8.22% | 39.16% | Britannia Industries |
| Revenue per Share (TTM) | $1 | $758 | Britannia Industries |
| Earnings per Share (Diluted) | $0.01 | $91.09 | Britannia Industries |
| Beta (Stock Volatility) | -0.21 | 0.53 | Evexia Lifecare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Evexia Lifecare vs Britannia Industries Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Evexia Lifecare | 2.04% | -2.44% | -10.31% | -17.36% | -21.26% | -43.50% |
| Britannia Industries | -2.06% | -1.74% | -3.74% | 0.05% | 16.44% | 22.78% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Evexia Lifecare | -52.15% | 10.50% | -98.58% | -98.58% | -98.58% | -98.58% |
| Britannia Industries | -1.53% | 55.07% | 57.10% | 264.66% | 2,641.07% | 4,805.02% |
News Based Sentiment: Evexia Lifecare vs Britannia Industries
Evexia Lifecare
News based Sentiment: MIXED
Evexia Lifecare reported strong financial results in Q2 2025, demonstrating significant revenue and profit growth. However, this positive news was offset by a valuation downgrade and concerns about the company's high P/E ratio, creating a mixed investment narrative for the month.
Britannia Industries
News based Sentiment: MIXED
October was a mixed month for Britannia Industries, with a slight stock decline countered by positive credit ratings, an analyst 'Buy' recommendation, and increased trading volume. While the initial dip warrants attention, the overall picture suggests continued investor interest and underlying financial stability, making it a moderately significant month.
Performance & Financial Health Analysis: Evexia Lifecare vs Britannia Industries
| Metric | EVEXIA | BRITANNIA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.77B | ₹1.45T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 1,939,017 | 314,870 |
| 90 Day Avg. Volume | 2,474,343 | 387,683 |
| Last Close | ₹2.00 | ₹5,887.00 |
| 52 Week Range | ₹1.86 - ₹3.73 | ₹4,506.00 - ₹6,336.00 |
| % from 52W High | -46.38% | -7.09% |
| All-Time High | ₹165.00 (Mar 15, 2021) | ₹6,469.90 (Sep 30, 2024) |
| % from All-Time High | -98.79% | -9.01% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.09% |
| Quarterly Earnings Growth | 1.63% | 0.03% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.12% |
| Operating Margin (TTM) | 0.04% | 0.15% |
| Return on Equity (TTM) | 0.00% | 0.50% |
| Debt to Equity (MRQ) | 82.72 | 28.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹4.94 | ₹180.83 |
| Cash per Share (MRQ) | ₹0.06 | ₹51.66 |
| Operating Cash Flow (TTM) | ₹-29,906,000 | ₹27.29B |
| Levered Free Cash Flow (TTM) | ₹9.30M | ₹21.79B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.57% |
| Last 12-Month Dividend | N/A | ₹148.50 |
Valuation & Enterprise Metrics Analysis: Evexia Lifecare vs Britannia Industries
| Metric | EVEXIA | BRITANNIA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 201.00 | 65.79 |
| Forward P/E | N/A | 73.65 |
| PEG Ratio | N/A | 21.92 |
| Price to Sales (TTM) | 3.39 | 7.91 |
| Price to Book (MRQ) | 0.41 | 33.14 |
| Market Capitalization | ||
| Market Capitalization | ₹3.77B | ₹1.45T |
| Enterprise Value | ₹5.74B | ₹1.44T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.16 | 7.91 |
| Enterprise to EBITDA | 113.42 | 45.45 |
| Risk & Other Metrics | ||
| Beta | -0.21 | 0.53 |
| Book Value per Share (MRQ) | ₹4.94 | ₹180.83 |
Financial Statements Comparison: Evexia Lifecare vs Britannia Industries
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EVEXIA | BRITANNIA |
|---|---|---|
| Revenue/Sales | ₹220.93M | ₹45.35B |
| Cost of Goods Sold | ₹202.76M | ₹27.59B |
| Gross Profit | ₹18.17M | ₹17.76B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹8.65M | ₹6.75B |
| EBITDA | ₹10.78M | ₹8.09B |
| Pre-Tax Income | ₹8.58M | ₹7.01B |
| Income Tax | ₹2.23M | ₹1.81B |
| Net Income (Profit) | ₹6.35M | ₹5.20B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EVEXIA | BRITANNIA |
|---|---|---|
| Cash & Equivalents | ₹41.44M | ₹1.33B |
| Total Current Assets | ₹1.18B | ₹39.14B |
| Total Current Liabilities | ₹793.14M | ₹36.18B |
| Long-Term Debt | ₹3.75B | ₹7.32B |
| Total Shareholders Equity | ₹4.66B | ₹43.81B |
| Retained Earnings | N/A | ₹40.36B |
| Property, Plant & Equipment | ₹223.76M | ₹27.35B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EVEXIA | BRITANNIA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EVEXIA | BRITANNIA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,939,017 | 314,870 |
| Average Daily Volume (90 Day) | 2,474,343 | 387,683 |
| Shares Outstanding | 1.88B | 240.87M |
| Float Shares | 528.29M | 117.62M |
| % Held by Insiders | 0.50% | 0.51% |
| % Held by Institutions | 0.05% | 0.25% |
Dividend Analysis & Yield Comparison: Evexia Lifecare vs Britannia Industries
| Metric | EVEXIA | BRITANNIA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹148.50 |
| Last 12-Month Dividend Yield | N/A | 2.57% |
| 3-Year Avg Annual Dividend | N/A | ₹73.50 |
| 3-Year Avg Dividend Yield | N/A | 1.42% |
| 3-Year Total Dividends | N/A | ₹220.50 |
| Ex-Dividend Date | N/A | Aug 04, 2025 |